Thomas C. Wicka

Novu LLC develops health technology platform. It offers solutions in the areas of health programming, community management, gamification mechanics, consumer-centered communication, rewards management, technology and data integration, health screening management, daily program management, and reporting and analytics. The company was founded by James C. Wicka, Thomas C. Wicka, and John D. Wicka in 2010 and is headquartered in Minneapolis, MN.

Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka.

Icario, Inc. is a health action company that leverages innovative technology, data science, and behavioral insights to improve health outcomes. The company is based in Minneapolis, MN and has subsidiaries in the United States. The company partners with health and wellness point solutions to drive enrollment and participation in personalized health action programs. Icario's health action programs are designed to meet the Medicare population where they are, moving them to take specific actions. The company's health platform focuses on healthcare risk assessments and HEDIS gap closure to mitigate member risk and provide quality. The platform combines demographic, clinical, and consumer data with behavioral science to personalize the member experience. Icario understands that it’s difficult to engage Medicaid members and has developed a framework for understanding this population to drive action. The company was founded in 2020 by Thomas C. Wicka. Marc Willard has been the CEO of the company since 2023.

IWCO Direct, Inc. provides direct mail marketing services. The firm offers integrated direct mail supply chain solution encompassing form, insert printing, envelope manufacturing, personalization, mail sorting, and postal optimization. Its products Mail-Gard engages in business continuity and disaster recovery services, and Recovery Builder assists planning and consulting services. The company was founded in 1969 and is headquartered in Chanhassen, MN.